Clinical Trials Logo

Clinical Trial Summary

The purpose of this exploratory study is to evaluate safety and effectiveness of treatment of juxta-anastomotic (re)stenosis with SUPERA stent by improving hemodynamic situation through obtuse shaping of the anastomosis.


Clinical Trial Description

Up to 50 patients undergoing percutaneous intervention due to juxta-anastomotic (re-)stenosis of the AV fistulas will be enrolled in this single-arm, prospective, multi-center CE marked study (IIT). Hemodialysis patients with failing radial-cephalic arteriovenous fistula (AVF) will receive treatment with the SUPERA stent and will be followed-up at 1, 3, 6 and 12 months after the procedure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05232760
Study type Observational
Source Klinikum Arnsberg
Contact Michael Lichtenberg, Dr.med.
Phone +49 02923 952 242
Email M.Lichtenberg@klinikum-hochsauerland.de
Status Recruiting
Phase
Start date March 17, 2022
Completion date August 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04399564 - Temporary vs.Long Term Hemodialysis Catheter on Central Vein Stenosis N/A
Terminated NCT02913274 - Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty N/A
Not yet recruiting NCT03068845 - Arteriovenous Fistula: Conventional Angioplasty vs Drug Eluting Balloon-assisted Maturation Intervention Clinical Trial Phase 3
Completed NCT01544907 - Prospective Randomized Trial Comparing DEB Versus Conventional PTA for the Treatment of Hemodialysis AVF or AVG Stenoses N/A
Recruiting NCT02632955 - Drug Eluting Balloon for Early Fistula Failure Trial N/A